CVP, CFO and Treasurer of Edwards Lifesciences Corp. (EW) Thomas M Abate sells 50,000 shares of EW on 02/23/2010 at an average price of $90.24 a share.

Edwards Lifesciences Corp. has a market cap of $5.16 billion; its shares were traded at around $91.26 with a P/E ratio of 29.9 and P/S ratio of 3.8. Edwards Lifesciences Corp. had an annual average earning growth of 6.9% over the past 5 years.

EW is in the portfolios of Ron Baron of Baron Funds, Richard Aster Jr of Meridian Fund, PRIMECAP Management, Jeremy Grantham of GMO LLC, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC, Chuck Royce of ROYCE & ASSOCIATES.

This is the annual revenues and earnings per share of EW over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of EW.

CEO Recent Trades:

• Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 02/09/2010 at the average price of 86.49, the price of the stock has increased by 5.52% since.


• Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 01/11/2010 at the average price of 90.93, the price of the stock has increased by 0.36% since.


• Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 12/08/2009 at the average price of 83.18, the price of the stock has increased by 9.71% since.


• Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 11/12/2009 at the average price of 80.52, the price of the stock has increased by 13.34% since.


• Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 10/13/2009 at the average price of 70.03, the price of the stock has increased by 30.32% since.

This is the insider trade history vs. stock price of EW. For the complete insider trading history of EW, click here.

Directors and Officers Recent Trades:

• Sell:: CVP, Strategy & Corp Dev John H Jr Kehl sold 30,250 shares of EW stock on 02/22/2010 at the average price of 90.92, the price of the stock has increased by 0.37% since.


• Sell:: CVP, CardioVations Surgcl Sys Paul C Redmond sold 8,600 shares of EW stock on 02/19/2010 at the average price of 91, the price of the stock has increased by 0.29% since.


• Sell:: Director David E I Pyott sold 15,729 shares of EW stock on 02/18/2010 at the average price of 90, the price of the stock has increased by 1.4% since.


• Sell:: CVP, Critical Care & Vascular Carlyn D Solomon sold 12,500 shares of EW stock on 02/18/2010 at the average price of 89.64, the price of the stock has increased by 1.81% since.


• Sell:: CVP, CardioVations Surgcl Sys Paul C Redmond sold 13,700 shares of EW stock on 02/17/2010 at the average price of 88.8, the price of the stock has increased by 2.77% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool